249 related articles for article (PubMed ID: 9461316)
1. Effects of testosterone replacement therapy on cortical and trabecular bone mineral density, vertebral body area and paraspinal muscle area in hypogonadal men.
Leifke E; Körner HC; Link TM; Behre HM; Peters PE; Nieschlag E
Eur J Endocrinol; 1998 Jan; 138(1):51-8. PubMed ID: 9461316
[TBL] [Abstract][Full Text] [Related]
2. Increase in bone density and lean body mass during testosterone administration in men with acquired hypogonadism.
Katznelson L; Finkelstein JS; Schoenfeld DA; Rosenthal DI; Anderson EJ; Klibanski A
J Clin Endocrinol Metab; 1996 Dec; 81(12):4358-65. PubMed ID: 8954042
[TBL] [Abstract][Full Text] [Related]
3. Effects of long-term testosterone substitutive therapy on bone mineral content in men with hypergonadotrophic hypogonadism.
Medras M; Jankowska EA; Rogucka E
Andrologia; 2001 Jan; 33(1):47-52. PubMed ID: 11167519
[TBL] [Abstract][Full Text] [Related]
4. Effects of testosterone and venesection on spinal and peripheral bone mineral in six hypogonadal men with hemochromatosis.
Diamond T; Stiel D; Posen S
J Bone Miner Res; 1991 Jan; 6(1):39-43. PubMed ID: 2048430
[TBL] [Abstract][Full Text] [Related]
5. Bone mineral density outcomes following long-term treatment with subcutaneous testosterone pellet implants in male hypogonadism.
Zacharin MR; Pua J; Kanumakala S
Clin Endocrinol (Oxf); 2003 Jun; 58(6):691-5. PubMed ID: 12780744
[TBL] [Abstract][Full Text] [Related]
6. Effect of testosterone replacement on trabecular architecture in hypogonadal men.
Benito M; Vasilic B; Wehrli FW; Bunker B; Wald M; Gomberg B; Wright AC; Zemel B; Cucchiara A; Snyder PJ
J Bone Miner Res; 2005 Oct; 20(10):1785-91. PubMed ID: 16160736
[TBL] [Abstract][Full Text] [Related]
7. Compromised Volumetric Bone Density and Microarchitecture in Men With Congenital Hypogonadotropic Hypogonadism.
Ostertag A; Papadakis GE; Collet C; Trabado S; Maione L; Pitteloud N; Bouligand J; De Vernejoul MC; Cohen-Solal M; Young J
J Clin Endocrinol Metab; 2021 Aug; 106(9):e3312-e3326. PubMed ID: 33725720
[TBL] [Abstract][Full Text] [Related]
8. Sublingual testosterone replacement improves muscle mass and strength, decreases bone resorption, and increases bone formation markers in hypogonadal men--a clinical research center study.
Wang C; Eyre DR; Clark R; Kleinberg D; Newman C; Iranmanesh A; Veldhuis J; Dudley RE; Berman N; Davidson T; Barstow TJ; Sinow R; Alexander G; Swerdloff RS
J Clin Endocrinol Metab; 1996 Oct; 81(10):3654-62. PubMed ID: 8855818
[TBL] [Abstract][Full Text] [Related]
9. Bone mineral density in hypogonadal men remains low after long-term testosterone replacement.
Ishizaka K; Suzuki M; Kageyama Y; Kihara K; Yoshida K
Asian J Androl; 2002 Jun; 4(2):117-21. PubMed ID: 12085102
[TBL] [Abstract][Full Text] [Related]
10. Long-term effect of testosterone therapy on bone mineral density in hypogonadal men.
Behre HM; Kliesch S; Leifke E; Link TM; Nieschlag E
J Clin Endocrinol Metab; 1997 Aug; 82(8):2386-90. PubMed ID: 9253305
[TBL] [Abstract][Full Text] [Related]
11. Using quantitative CT to assess adipose distribution in adult men with acquired hypogonadism.
Katznelson L; Rosenthal DI; Rosol MS; Anderson EJ; Hayden DL; Schoenfeld DA; Klibanski A
AJR Am J Roentgenol; 1998 Feb; 170(2):423-7. PubMed ID: 9456958
[TBL] [Abstract][Full Text] [Related]
12. Testosterone Therapy Effects on Bone Mass and Turnover in Hypogonadal Men with Type 2 Diabetes.
Colleluori G; Aguirre L; Napoli N; Qualls C; Villareal DT; Armamento-Villareal R
J Clin Endocrinol Metab; 2021 Jul; 106(8):e3058-e3068. PubMed ID: 33735389
[TBL] [Abstract][Full Text] [Related]
13. Effects of testosterone replacement in hypogonadal men.
Snyder PJ; Peachey H; Berlin JA; Hannoush P; Haddad G; Dlewati A; Santanna J; Loh L; Lenrow DA; Holmes JH; Kapoor SC; Atkinson LE; Strom BL
J Clin Endocrinol Metab; 2000 Aug; 85(8):2670-7. PubMed ID: 10946864
[TBL] [Abstract][Full Text] [Related]
14. Long-term effect of testosterone replacement therapy on bone in hypogonadal men with Klinefelter Syndrome.
Tahani N; Nieddu L; Prossomariti G; Spaziani M; Granato S; Carlomagno F; Anzuini A; Lenzi A; Radicioni AF; Romagnoli E
Endocrine; 2018 Aug; 61(2):327-335. PubMed ID: 29696556
[TBL] [Abstract][Full Text] [Related]
15. Effects of long-acting testosterone undecanoate on bone mineral density in middle-aged men with late-onset hypogonadism and metabolic syndrome: results from a 36 months controlled study.
Aversa A; Bruzziches R; Francomano D; Greco EA; Fornari R; Di Luigi L; Lenzi A; Migliaccio S
Aging Male; 2012 Jun; 15(2):96-102. PubMed ID: 22439807
[TBL] [Abstract][Full Text] [Related]
16. The effect of hypogonadism and testosterone-enhancing therapy on alkaline phosphatase and bone mineral density.
Dabaja AA; Bryson CF; Schlegel PN; Paduch DA
BJU Int; 2015 Mar; 115(3):480-5. PubMed ID: 25046796
[TBL] [Abstract][Full Text] [Related]
17. Bone mineral density, body composition and bone turnover in patients with congenital hypogonadotropic hypogonadism.
Laitinen EM; Hero M; Vaaralahti K; Tommiska J; Raivio T
Int J Androl; 2012 Aug; 35(4):534-40. PubMed ID: 22248317
[TBL] [Abstract][Full Text] [Related]
18. Treatment of isolated hypogonadotropic hypogonadism effect on bone mineral density and bone turnover.
Guo CY; Jones TH; Eastell R
J Clin Endocrinol Metab; 1997 Feb; 82(2):658-65. PubMed ID: 9024272
[TBL] [Abstract][Full Text] [Related]
19. Aromatase Inhibitors Plus Weight Loss Improves the Hormonal Profile of Obese Hypogonadal Men Without Causing Major Side Effects.
Colleluori G; Chen R; Turin CG; Vigevano F; Qualls C; Johnson B; Mediwala S; Villareal DT; Armamento-Villareal R
Front Endocrinol (Lausanne); 2020; 11():277. PubMed ID: 32499757
[No Abstract] [Full Text] [Related]
20. Site-specific effect of testosterone on bone mineral density in male hypogonadism.
Choi HR; Lim SK; Lee MS
J Korean Med Sci; 1995 Dec; 10(6):431-5. PubMed ID: 8924228
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]